5342 Investors following Jubilant Life. Share this News with them.
0
Like this story, share it with millions of investors on M3
Jubilant Q1 net profit seen down at Rs 105.5 cr: Religare
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Jubilant Organosys' June quarter sales are expected to go up by 7.2% to Rs 885.9 crore on YoY basis.
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Jubilant Organosys ' June quarter sales are expected to go up by 7.2% to Rs 885.9 crore on YoY basis.
The company's net profit is expected to go down by 12.3% to Rs 105.5 crore on YoY basis.